vTv Therapeutics Inc.

VTVT | NASDAQ

Price Alert Chart Builder DCF Calculator

$31.64

+$0.34 (+1.09%)

Sep 22, 2026, 1:24 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.09%

(1D)

Rating

Updated: Aug 21, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $82.82M

1D Range

31.32 31.75

52W Range

19.50 44

Valuation (TTM)

PE -284.55

PB 1.04

EV/EBITDA 0.74

Valuation (NTM)

Forward PE N/A

Forward PEG -1.33

Price Target $42

Cash Flow

FCF Yield -9.3%

SBC Adj. FCF Yield -15.6%

SBC Impact -67.7%

Margins

Gross Margin 100.0%

Operating Margin -25.1%

FCF Margin -20.6%

Growth (CAGR)

Revenue 3Y | 5Y 1499.6% | 37.9%

Dil EPS 3Y | 5Y 99.8% | 45.5%

FCF 3Y | 5Y 41.4% | 4.6%

Returns

ROA -5.4%

ROE -6.3%

ROIC -11.5%

Financial Health

Net Cash

$86.64M

Current Ratio 12.48

Interest Coverage -1,541.83

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

vTv Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on creating orally administered treatments, with a significant emphasis on diabetes. Its pipel...

Sector Healthcare

Industry Biotechnology

Employees 26

IPO Date Jul 29, 2015

Website www.vtvtherapeutics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 5, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$42

Upside

+32.74%

Buy (2)

Hold (0)

Sell (0)

Analyst Details ➞